You’ll recall last week that clinical trials of the COVID-19 vaccine candidate from Oxford / AstraZeneca were paused:
News now that AstraZeneca said it received notification from the UK’s Medicines Health Regulatory Authority that it was safe to resume clinical trials.
News now that AstraZeneca said it received notification from the UK’s Medicines Health Regulatory Authority that it was safe to resume clinical trials.